A biomarker that shows the progression of Parkinson’s disease in the brain has been identified by researchers, opening the door to better diagnosis and treatment of the degenerative disease.
A biomarker that shows the progression of Parkinson’s disease in the brain has been identified by researchers, opening the door to better diagnosis and treatment of the degenerative disease.